“Bad Pharma” is getting better!
After much debate, Brussels agreed on European drug law changes, effective in 2016. To improve transparency and safety, pharma studies in humans will have to publish all results, including negative findings.
As Ben Goldacre explained so lucidly in Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients, scientists’ and study sponsors’ tendencies to only publish findings that are interesting and/or support certain types of conclusions have skewed drug licensing and killed people.
(Bod FAW mah vee awed BESS ah.)